FDA Validates Tool For Incorporating Patient Preferences In Regulatory Decisions
This article was originally published in The Gray Sheet
Executive Summary
A pilot study that explored how much risk patients would be willing to tolerate from a device implant in order to achieve significant weight loss is helping CDRH regulators understand how to accurately and reliably measure patient preferences. The goal is to start incorporating those preferences into regulatory decisions for certain devices, officials explained at a Sept. 18-19 workshop.
You may also be interested in...
Expanding The Medtech Toolbox: US FDA's 'Medical Device Development Tools' Program Rolls Out
Three years in the making, FDA has released a final guidance for medical device development tools that would allow developers to qualify their MDDTs and give medical device manufactures access to new tools that could help them prove safety and effectiveness of their products sooner.
US FDA's Device-Focused Patient Engagement AdComm Tackles Trial Challenges
FDA's new Patient Engagement Advisory Committee will discuss patient perspectives on device clinical trials at its first scheduled meeting.
The Patient Perspective: Upcoming US FDA Device Center Studies Put Device-Users In Front Seat
A patient's point of view is paramount as the Center for Devices and Radiological Health embarks on a plan to conduct patient-perspective studies to ascertain what device-users want and value when it comes to health care. But don't call it a "survey" – "this is real research," CDRH compliance chief Robin Newman says.